XML 28 R10.htm IDEA: XBRL DOCUMENT v3.25.3
Financial Instruments
 12 Months Ended
Sep. 27, 2025
Fair Value Disclosures [Abstract]  
Financial Instruments
3. Financial Instruments
The carrying values of the Company’s accounts receivable and accounts payable, approximate their fair values due to the short period of time to maturity or repayment. The following table summarizes cash, cash equivalents and marketable securities by investment category as of September 27, 2025, and September 28, 2024:

September 27, 2025
Amortized CostUnrealized GainUnrealized LossEstimated Fair ValueCash and Cash EquivalentsMarketable Securities
Cash$158,556 $— $— $158,556 $158,556 $— 
Level 1:
Money market funds16,112 — — 16,112 16,112 — 
Subtotal16,112 — — 16,112 16,112 — 
Level 2:
U.S. Treasury securities52,834 32 (8)52,858 — 52,858 
Subtotal52,834 32 (8)52,858 — 52,858 
Total227,502 32 (8)227,526 174,668 52,858 
September 28, 2024
Amortized CostUnrealized GainUnrealized LossEstimated Fair ValueCash and Cash EquivalentsMarketable Securities
Cash$144,184 $— $— $144,184 $144,184 $— 
Level 1:
Money market funds25,548 — — 25,548 25,548 — 
Subtotal25,548 — — 25,548 25,548 — 
Level 2:
U.S. Treasury securities51,304 122 — 51,426 — 51,426 
Subtotal51,304 122 — 51,426 — 51,426 
Total221,036 122 — 221,158 169,732 51,426 
Marketable Securities
As of September 27, 2025, and September 28, 2024, the Company held no securities with original maturities exceeding one year. There were no realized gains or losses on sales of marketable securities during fiscal 2025, and fiscal 2024.
For securities in an unrealized loss position, the Company does not intend to sell the securities, and it is more-likely-than-not that it will not be required to sell before recovery of their amortized cost basis. The Company evaluated whether the decline in fair value resulted from credit losses or other factors and concluded these amounts were related to temporary fluctuations in value of the securities and were due primarily to changes in interest rates and market conditions of the underlying securities. Accordingly, an allowance for credit losses was deemed unnecessary for these securities as of September 27, 2025.
Accrued interest receivable related to our marketable securities was nominal as of September 27, 2025, and September 28, 2024. No accrued interest receivables were written off during fiscal 2025, and fiscal 2024.